Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 498,533 | 397,328 | 378,283 | 404,642 | 446,120 |
| Cost of Goods | 315,034 | 287,094 | 323,849 | 299,393 | 363,040 |
| Gross Profit | 183,499 | 110,234 | 54,434 | 105,249 | 83,080 |
| Operating Expenses | 125,742 | 133,463 | 167,557 | 124,555 | 177,480 |
| Operating Income | 57,791 | -23,135 | -112,274 | -18,913 | -94,360 |
| Interest Expense | 39,899 | 38,829 | 42,209 | 43,886 | 43,281 |
| Other Income | -4,548 | 4,853 | 180,759 | 6,572 | 4,461 |
| Pre-tax Income | 13,344 | -57,111 | 26,276 | -56,227 | -133,180 |
| Income Tax | -108,173 | 7,792 | 389,668 | -5,701 | -8,428 |
| Net Income Continuous | 121,517 | -64,903 | -363,392 | -50,526 | -124,752 |
| Minority Interests | 6,450 | -32,775 | -98,386 | -33,624 | -76,871 |
| Net Income | $115,067 | $-32,128 | $-265,006 | $-16,902 | $-47,881 |
| EPS Basic Total Ops | 0.78 | -0.21 | -2.03 | -0.13 | -0.37 |
| EPS Basic Continuous Ops | 0.83 | -0.42 | -2.78 | -0.39 | -0.98 |
| EPS Diluted Total Ops | 0.78 | -0.21 | -2.03 | -0.13 | -0.37 |
| EPS Diluted Continuous Ops | 0.82 | -0.42 | -2.78 | -0.39 | -0.98 |
| EBITDA(a) | $117,878 | $32,797 | $-57,285 | $33,410 | $-7,498 |